Mr Thomas J Pazik, MD | |
5890 W 13th St, Ste 101, Greeley, CO 80634-4821 | |
(970) 348-0020 | |
(970) 348-0044 |
Full Name | Mr Thomas J Pazik |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 5890 W 13th St, Greeley, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609850056 | NPI | - | NPPES |
PA38719 | Other | CO | BLUE CROSS BLUE SHIELD |
01340819 | Medicaid | CO | |
P00059087 | Other | RAILROAD MEDICARE | |
105773800 | Other | DEPARTMENT OF LABOR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 34081 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Thomas J Pazik, MD 5890 W 13th St, Ste 101, Greeley, CO 80634-4821 Ph: (970) 348-0020 | Mr Thomas J Pazik, MD 5890 W 13th St, Ste 101, Greeley, CO 80634-4821 Ph: (970) 348-0020 |
News Archive
Over the last decade, research has revealed more about the human gut microbiome—the environment within the gastrointestinal tract—where microbes, especially bacteria, reside. Recently, more has become known about the function of those microbes and the microbiome's connection with health and disease.
Boston Scientific Corporation today announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2™ Paclitaxel-Eluting Stent System or the Express® bare-metal stent.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
Women with early-stage, HER2-positive breast cancer who are unable to use trastuzumab may benefit from adjuvant lapatinib treatment, suggest phase III trial findings published in Lancet Oncology.
› Verified 2 days ago
Dr. Randy M Bussey, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5890 W 13th St, 101, Greeley, CO 80634 Phone: 970-348-0020 Fax: 970-348-0055 | |
Dr. Mark D Grossnickle, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 16th St, Greeley, CO 80631 Phone: 970-350-2427 Fax: 970-350-2421 | |
Garrett Micah Snyder, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5890 W 13th St Ste 101, Greeley, CO 80634 Phone: 970-810-0020 | |
Gilbert Anderson, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5890 W 13th St, Suite 101, Greeley, CO 80634 Phone: 970-348-0020 Fax: 970-348-0055 | |
Dr. Steven D Sides, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 16th St, Greeley, CO 80631 Phone: 970-348-0020 Fax: 970-348-0055 | |
Dr. Brett P Hunter, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 16th St, Greeley, CO 80631 Phone: 970-350-2427 Fax: 970-350-2421 |